Phathom Pharmaceuticals Inc (PHAT) earnings · rev $175.1M
These earnings events as JSON? API free 100/dayPhathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
This PHAT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.
When the next PHAT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 216.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PHAT research stays on the stock page; the tape stays on the quote page.
PHAT earnings FAQ
What are PHAT's latest revenue and net income?
Latest cached Phathom Pharmaceuticals Inc (PHAT) revenue for Dec 31, 2025 was $175.1M. Net income was -$221.2M. Statements: https://lician.com/financials/phat
What is PHAT's latest diluted EPS?
Latest cached Phathom Pharmaceuticals Inc (PHAT) diluted EPS for Dec 31, 2025 was -$3.03.
What period does the latest PHAT earnings print cover?
The latest cached Phathom Pharmaceuticals Inc (PHAT) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did PHAT revenue change from the prior cached period?
Cached Phathom Pharmaceuticals Inc (PHAT) revenue was up 216.9% from $55.3M (Dec 31, 2024) to $175.1M (Dec 31, 2025). Statements: https://lician.com/financials/phat
Where are PHAT earnings listed?
Cached earnings facts for Phathom Pharmaceuticals Inc (PHAT) are listed at https://lician.com/earnings/phat. Statements: https://lician.com/financials/phat
Not investment advice.